Published in Nat Med on July 06, 2012
Prenatal Cytogenetic Diagnosis by Array-Based Copy Number Analysis (Microarray) | NCT01279733
Preterm labor: one syndrome, many causes. Science (2014) 2.61
Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet (2013) 1.99
Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet (2015) 1.21
Noninvasive prenatal testing: the future is now. Rev Obstet Gynecol (2013) 1.10
Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA. Proc Natl Acad Sci U S A (2015) 0.99
Global gene expression analysis of amniotic fluid cell-free RNA from recipient twins with twin-twin transfusion syndrome. Prenat Diagn (2013) 0.99
Non-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future Prospects. J Clin Med (2014) 0.85
Prenatal diagnostics: Fetal genes in mother's blood. Nature (2012) 0.80
Finding novel molecular connections between developmental processes and disease. PLoS Comput Biol (2014) 0.79
Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD. PLoS One (2013) 0.78
Pitfalls of DNA Quantification Using DNA-Binding Fluorescent Dyes and Suggested Solutions. PLoS One (2016) 0.78
Antisense oligonucleotides delivered to the amniotic cavity in utero modulate gene expression in the postnatal mouse. Nucleic Acids Res (2016) 0.77
Treating trisomies: Prenatal Down's syndrome therapies explored in mice. Nat Med (2016) 0.76
Changing Paradigms in Down Syndrome: The First International Conference of the Trisomy 21 Research Society. Mol Syndromol (2016) 0.75
To know or not to know the genomic sequence of a fetus. Nat Rev Genet (2012) 0.75
Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues. Appl Clin Genet (2016) 0.75
Prenatal and pre-implantation genetic diagnosis. Nat Rev Genet (2016) 0.75
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays. PLoS One (2017) 0.75
Noninvasive Digital Detection of Fetal DNA in Plasma of 4-Week-Pregnant Women following In Vitro Fertilization and Embryo Transfer. PLoS One (2015) 0.75
The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science (2006) 25.99
The NCBI dbGaP database of genotypes and phenotypes. Nat Genet (2007) 17.93
Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet (2010) 13.70
Presence of fetal DNA in maternal plasma and serum. Lancet (1997) 9.01
Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A (2008) 8.38
DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet (2009) 7.61
Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet (1998) 6.88
Detection and characterization of placental microRNAs in maternal plasma. Clin Chem (2008) 6.40
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A (2008) 5.94
Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med (2010) 5.54
DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med (2011) 4.98
Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol (2012) 4.78
Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ (2011) 4.50
Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med (1998) 4.29
Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol (2011) 4.18
Educating health-care professionals about genetics and genomics. Nat Rev Genet (2007) 4.04
Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem (2002) 3.72
Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med (2007) 3.34
ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol (2007) 3.19
DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med (2012) 3.18
Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci U S A (2007) 3.13
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem (2004) 2.79
Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn (2012) 2.79
Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem (2008) 2.78
Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol (2007) 2.78
Prenatal determination of fetal RhD type by DNA amplification. N Engl J Med (1993) 2.53
Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol (2012) 2.39
Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing. Clin Chem (2010) 2.38
Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One (2011) 2.29
Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med (2011) 2.19
Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol (2012) 2.17
Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem (2011) 2.17
Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod (2009) 2.17
Identification of pregnancy-associated microRNAs in maternal plasma. Clin Chem (2010) 1.95
Transcriptome analysis of human autosomal trisomy. Hum Mol Genet (2002) 1.90
mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci U S A (2003) 1.89
Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem (2006) 1.85
Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med (2011) 1.85
Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A (2005) 1.81
Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci U S A (2009) 1.81
Detection of aneuploidy with digital polymerase chain reaction. Anal Chem (2007) 1.80
Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases. Prenat Diagn (2009) 1.78
Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion (2002) 1.76
Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time. Obstet Gynecol (2005) 1.75
Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn (2002) 1.74
Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem (2002) 1.72
Comparative genomic hybridization-array analysis enhances the detection of aneuploidies and submicroscopic imbalances in spontaneous miscarriages. Am J Hum Genet (2004) 1.69
Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci U S A (2008) 1.64
Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA (2011) 1.59
ACOG Committee Opinion No. 446: array comparative genomic hybridization in prenatal diagnosis. Obstet Gynecol (2009) 1.52
Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn (2007) 1.46
Presence of fetal RNA in maternal plasma. Clin Chem (2000) 1.45
Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. Prenat Diagn (2012) 1.45
High resolution array analysis: diagnosing pregnancies with abnormal ultrasound findings. J Med Genet (2009) 1.45
Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum Reprod Update (2004) 1.43
Sharpening the tools: a summary of a National Institutes of Health workshop on new technologies for detection of fetal cells in maternal blood for early prenatal diagnosis. J Matern Fetal Neonatal Med (2006) 1.43
Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles. Clin Chem (2010) 1.42
Comparison of microarray-based detection rates for cytogenetic abnormalities in prenatal and neonatal specimens. Prenat Diagn (2008) 1.41
Diagnostic utility of array-based comparative genomic hybridization (aCGH) in a prenatal setting. Prenat Diagn (2010) 1.40
Get ready for the flood of fetal gene screening. Nature (2011) 1.38
The transcriptome of the fetal inflammatory response syndrome. Am J Reprod Immunol (2010) 1.37
Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid. JAMA (2005) 1.36
Identification of clinically significant, submicroscopic chromosome alterations and UPD in fetuses with ultrasound anomalies using genome-wide 250k SNP array analysis. J Med Genet (2010) 1.34
Transcriptomic analysis of cell-free fetal RNA suggests a specific molecular phenotype in trisomy 18. Hum Genet (2010) 1.32
The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta (2010) 1.32
Whole-genome microarray analysis in prenatal specimens identifies clinically significant chromosome alterations without increase in results of unclear significance compared to targeted microarray. Prenat Diagn (2009) 1.30
Use of array comparative genomic hybridization for prenatal diagnosis of fetuses with sonographic anomalies and normal metaphase karyotype. Prenat Diagn (2009) 1.29
Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol (2006) 1.29
Genes on the Web--direct-to-consumer marketing of genetic testing. N Engl J Med (2006) 1.27
Placental-specific microRNA in maternal circulation--identification of appropriate pregnancy-associated microRNAs with diagnostic potential. J Reprod Immunol (2011) 1.24
Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood (2011) 1.23
Whole-genome array CGH identifies pathogenic copy number variations in fetuses with major malformations and a normal karyotype. Clin Genet (2011) 1.22
The amniotic fluid transcriptome: a source of novel information about human fetal development. Obstet Gynecol (2012) 1.20
Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. Clin Chem (2009) 1.18
Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion (2011) 1.16
Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet (2010) 1.16
Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia. Clin Chem (2012) 1.15
Ethical challenges in providing noninvasive prenatal diagnosis. Curr Opin Obstet Gynecol (2010) 1.15
A transcriptional profile of the decidua in preeclampsia. Am J Obstet Gynecol (2011) 1.14
Practical and ethical considerations of noninvasive prenatal diagnosis. JAMA (2009) 1.11
High-resolution array genomic hybridization in prenatal diagnosis. Prenat Diagn (2009) 1.09
Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood. J Clin Invest (2007) 1.09
All Our Babies Cohort Study: recruitment of a cohort to predict women at risk of preterm birth through the examination of gene expression profiles and the environment. BMC Pregnancy Childbirth (2010) 1.08
Oxidative stress: a bridge between Down's syndrome and Alzheimer's disease. Neurobiol Aging (2006) 1.07
Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism. J Med Genet (2004) 1.06
Should non-invasiveness change informed consent procedures for prenatal diagnosis? Health Care Anal (2011) 1.06
The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin Chem (2003) 1.05
Noninvasive prenatal detection of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis: a review of the current state of the art. BJOG (2009) 1.04
Application of a target array comparative genomic hybridization to prenatal diagnosis. BMC Med Genet (2010) 1.04
Gene expression analysis of cultured amniotic fluid cell with Down syndrome by DNA microarray. J Korean Med Sci (2005) 1.02
Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J Med Genet (2004) 1.00
Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. BJOG (2011) 0.98
Genome-wide expression analysis of cultured trophoblast with trisomy 21 karyotype. Hum Reprod (2007) 0.98
Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications. Public Health Genomics (2010) 0.96
Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia. Prenat Diagn (2007) 0.96
Array-based comparative genomic hybridization (aCGH) in the genetic evaluation of stillbirth. Am J Med Genet A (2009) 0.92
Proof of concept study to assess fetal gene expression in amniotic fluid by nanoarray PCR. J Mol Diagn (2011) 0.90
Incremental cost of non-invasive prenatal diagnosis versus invasive prenatal diagnosis of fetal sex in England. Prenat Diagn (2011) 0.89
Placenta-derived fetal specific mRNA is more readily detectable in maternal plasma than in whole blood. PLoS One (2009) 0.89